FDA Inspection Readiness

FDA inspection readiness means your people, records, and stories hold up when investigators arrive. Regulatory inspections look at more than binders: they test whether submissions match operations, whether commitments were met, and whether SMEs can explain decisions without contradiction. Pre-approval, for-cause, and routine surveillance inspections each carry different pressure points across manufacturing, clinical oversight, pharmacovigilance interfaces, and device design controls.

Viltis prepares sponsors and sites with targeted readiness work. We review regulatory submission history against current processes, identify high-risk topics (data integrity, CAPA effectiveness, complaint handling, clinical monitoring, device design history), and run mock interviews so SMEs practice concise, accurate answers. We help organize front-room and back-room roles, document retrieval paths, and escalation rules for when questions go beyond prepared scope or into another function’s ownership.

Readiness is not a last-week scramble if you treat it as a standing program. We help you close documentation gaps early, align regulatory and quality narratives, and keep commitment trackers current so inspection week is execution, not discovery. When Form 483 observations or discussions follow, we support response drafting that addresses root cause without over-committing the organization to timelines it cannot meet.

Investigators notice when SMEs contradict the dossier or each other. Timed mock sessions that include RA, QA, and manufacturing together expose those cracks while you still have time to fix the story and the records behind it, including how commitments from prior meetings were closed. For remote or hybrid inspection models, we also help you prepare screen-sharing protocols, controlled document projection, and back-room chat discipline so digital logistics do not create the appearance of delay or concealment.

FDA inspection readiness support often includes

• Risk-based readiness assessments tied to product and site history
• Mock inspections and SME coaching for regulatory topics
• Submission-to-floor traceability checks for key claims and controls
• War-room logistics, document maps, and communication protocols
• Review of prior FDA commitments and correspondence status
• Cross-functional alignment between RA, QA, clinical, and manufacturing
• Post-inspection response drafting support for observations

Inspectors notice preparation. Viltis helps you walk in organized, consistent, and ready to show how your regulatory pledges show up in daily work on the floor and in the files. Calm, consistent answers beat polished slides every time investigators are in the room.